INTRODUCTION
Axillary lymph node metastasis (ALNM) is the single most important prognostic factor for patients with breast cancer.(1) The incidence of ALNM in breast cancer usually increases according to the tumor size, but the phenomena is inconsistent due to the fact that ALNM in breast cancer patients is the result of a complex of factors composed of genetic, epigenetic, ethnic, environmental and biological characteristics.
Determining the factors affecting ALNM in patients with early breast cancer is essential for personalized therapy with a precise risk assessment of each patient. Gonza@ lezVela et al. (2) reported that the predictors of ALNM are a tumor size over 2 cm, an infiltrative margin and a high Ki-67 index. Some investigators have suggested that ALNM is related with a young age at presentation. One study in Southeast Asia has reported that the tumor size, the invasive ductal and lobular cell type, lymphovascular invasion (LVI) and the progesterone receptor status are independent predictors of ALNM in Asian patients with breast cancer.(3) LVI has also been proved to be a strong predictive factor for ALNM in many studies, but it has still not been fully investigated. (4) (5) (6) After sentinel lymph node biopsy was introduced in breast cancer surgery, it has been replacing the standard level I/II axillary lymph node dissection (ALND) for the staging work-up and regional therapy in the clinically negative axilla. The American Society of Clinical Oncology Purpose: Axillary lymph node metastasis (ALNM) can occur even in breast cancer smaller than 2 cm in size. This study was performed to investigate the clinicopathologic factors that affect node metastasis in T1 breast cancer. Methods: We reviewed the medical record of 206 T1 breast cancer patients and we divided them into two groups according to the presence or absence of lymph node metastasis. We analyzed the association between ALNM and various clinicopathological predictive factors such as age, tumor size (T1a, T1b, T1c), multiplicity, the histologic grade, the nuclear grade, the presence of lymphovascular invasion (LVI), the estrogen and progesterone receptor status, an HER2/neu expression, the Ki-67 labeling index and the bcl-2 expression. Results: One hundred and thirty-nine were the node negative group (T1N0) and the remaining 67 cases were allotted to the node positive group (T1N1-3). On the univariate analysis, age (p= 0.011), LVI (p <0.001), histologic grade (p=0.019), HER2/ neu (p <0.005), Ki-67 (p=0.012) and bcl-2 (p=0.026) were the statistically significant predictive factors related to node metastasis. But on the multivariate analysis, LVI (p <0.001) and HER2/neu (p=0.009) were the statistically significant factors related to node metastasis. Conclusion: LVI and HER2/neu overexpression were related to the increased incidence of ALNM in T1 breast cancer patients. LVI was the most predictive factor of ALNM. 
Clinicopathologic parameters
We analyzed the prognostic factors such as age at diagnosis, the operative methods, tumor size (T1a, T1b, and T1c), multiplicity, the histologic grade (HG), the nuclear grade (NG), the presence of lymphovascular invasion (LVI), the estrogen receptor (ER) and progesterone receptor (PgR) status, the HER2/neu expression, the Ki-67 labelling index and the bcl-2 expression in each group.
The operative methods were breast conserving surgery (BCS) or mastectomy with sentinel node biopsy in all cases.
Standard ALND was performed when the sentinel LN biopsy was positive in the frozen biopsy. We measured the primary tumors to the nearest 0.1 cm increment and subdivided them into T1a, T1b, and T1c according to the definition of tumor size. T1a was defined as tumor larger than 0.1 cm but not larger than 0.5 cm, T1b was defined as larger than 0.5 cm but not larger than 1 cm, and T1c was defined as larger than 1 cm but not larger than 2 cm.
We divided the patients by the age of 40 yr and we On the univariate analysis, age at diagnosis, HG, LVI, HER2/neu expression, the Ki-67 labeling index and the bcl-2 expression were statistically significant prognostic factors that were related to node metastasis in the T1 breast cancer patients. On the multivariate analysis, LVI (p<0.001) and HER2/neu expression (p=0.009) were significantly associated with node metastasis in T1 breast cancer patients (Table 2) . tumors, tumor multiplicity didn' t show a relation with the presence of ALNM. Regarding the operative methods, BCS was performed for 92.2% of the patients and mastectomy was performed for 7.8% of the patients and both types of operations showed a similar percentage of multiplicity (11.1% for BCS and 12.5% for mastectomy, p=0.860).
But because the BCS group has the possibility of incidental multiple tumors that were not detected on preoperative evaluations, this can be a limitation of our study.
The importance of the HG as a prognostic factor in breast cancer has been clearly proved in numerous clinical studies. The higher grade tumors (poorly differentiated)
in breast cancer patients show the higher rate of distant metastasis and poorer survival than do the lower grade tumors. (24, 25) Our study also demonstrated that the HG 2 and 3 tumors had more increased in the node positive than the node negative T1 group and this was statistically significant on univariate analysis, but not on multivatiate analysis. This is also considered as a biased result that was possibly caused by the small sample size of this study.
Our study showed that the Ki-67 expression was increased in the node positive group and it was statistically significant on univariate analysis, but not on multivariate analysis. When we used two cutoff values of 10% or 15% to analyze the relation between Ki-67 and ALNM, the 10% cutoff value was more statistically significant than the 15% cutoff value. There are some controversies about the proper cutoff values of Ki-67. In one meta-analysis, some studies used 10% as the cut-off (arbitrary value), whereas others chose the mean, the median, the optimal cut-off value or arbitrary values, and these differences might be responsible for the difficulty to determine a standard threshold in daily practice. 
CONCLUSION
LVI and HER2/neu overexpression were related to the increased incidence of ALNM in T1 breast cancer patients.
Careful assessment of axillary lymph node is mandatory in the presence of LVI or HER2/neu amplification in preoperative biopsy specimen.
